Nanjing Chia-Tai Tianqing Pharmaceutical

Nanjing Chia-Tai Tianqing Pharmaceutical (NJCTTQ) is a prominent Chinese pharmaceutical company and a key subsidiary of Sino Biopharmaceutical Limited. The company specializes in the research, development, manufacturing, and commercialization of high-quality medicines, with a core focus on cardiovascular, metabolic, and digestive system diseases. NJCTTQ is recognized for its extensive portfolio of cardiovascular treatments, including several market-leading generic and innovative products. Operating out of Nanjing, the company maintains large-scale manufacturing facilities that adhere to international GMP standards. As a vital part of the Sino Biopharm group, NJCTTQ continues to expand its R&D capabilities to address unmet medical needs in the Chinese and global markets.